HIV-AIDS Clinical Trial: HIV Virus Defeats Naturally
A reduced body oxygen level is a hallmark for pathological changes in HIV/AIDS. This was noted in numerous medical articles (Wang et al. 1993; Mootsikapun et al. 1996; Khare & Sharland 1999; Pellicelli et al. 2001; Zhang et al. 2002; Deshmane et al. 2009; Long et al. 2009). Low body-oxygen levels are known to suppress immunity, increase inflammation, and lead to opportunistic infection, as well as a medical fact. Therefore, it makes sense to assume that increasing body-oxygen levels will help reduce the HIV/AIDS virus-related effects.
Soviet medical doctors carried out a clinical study on HIV-AIDS patients in Kiev Scientific and Research Institute of Epidemiology and Infectious Diseases. As an adjunct therapy to standard medications, these doctors used the Buteyko breath therapy to increase body-oxygen and improve their immune systems.
These doctors found that the body-oxygen (Buteyko control test) accurately indicated the stage of disease and symptoms. Restoring normal breathing eliminated most of the pronounced signs of the disease. The table below shows the results of the Buteyko technique on the main symptoms that participants experienced prior to and after the trial. This breathing technique was added to the standard medical protocols.
These are the preliminary conclusions of the Buteyko therapy: Positive symptoms have been observed with the Buteyko technique. 2. AIDS patients have never experienced side effects or complications from the Buteyko therapy. 3. Regular psychotherapy was ineffective, and four of the patients’ conditions got worse.
These preliminary conclusions can be drawn after treatment with the Buteyko Method: The positive effects of the Buteyko approach have led to improved clinical symptoms. 2. AIDS patients have never experienced side effects or complications from the Buteyko therapy. 3. Regular psychotherapy using regular methods proved ineffective. Four patients suffered from worsening health.
Signatures of the trial coordinators: Director of KSRIEID and vice-Academician of Academy of Medical Sciences of USSR. Professor A. F. Fololov Conductor of this trial K.P. Buteyko MD Executive of trial V.A. Novosselov, MD Physician for the AIDS Section at the Institute (KSRIEID). S.V. Fedorchenko, MD
Summary of HIV/AIDS findings
Russian and Ukrainian doctors discovered that HIV-AIDS patients respond well to their DIY body oxygen test results. Because low cell oxygenation suppresses immunity, this is a natural conclusion. Correcting abnormal breathing patterns, which are found in 100% of HIV-AIDS patients, is the basis of therapy that targets the real cause of HIV/AIDS: tissue hypoxia.
Deshmane SL1, Mukerjee R, Fan S, Del Valle L, Michiels C, Sweet T, Rom I, Khalili K, Rappaport J, Amini S, Sawaya BE. Activation of the oxidative stress pathway by HIV-1 Vpr leads to induction of hypoxia-inducible factor 1alpha expression, J Biol Chem. 2009 Apr 24;284(17):11364-73. doi: 10.1074/jbc.M809266200. Epub 2009 Feb 9.
Khare MD, Sharland M. Pulmonary manifestations of pediatric HIV infection, Indian J Pediatr. 1999 Nov-Dec;66(6):895-904.
Mootsikapun P1, Chetchotisakd P, Intarapoka B. Pulmonary infections in HIV infected patients, J Med Assoc Thai. 1996 Aug;79(8):477-85.
Pellicelli AM1, Barbaro G, Palmieri F, Girardi E, D’Ambrosio C, Rianda A, Barbarini G, Frigiotti D, Borgia MC, Petrosillo N. Primary pulmonary hypertension in HIV patients: a systematic review, Angiology. 2001 Jan;52(1):31-41.
Zhang W1, Liu HT. MAPK signal pathways in the regulation of cell proliferation in mammalian cells, Cell Res. 2002 Mar;12(1):9-18.
Wang MZ1, Cai BQ, Li LY, Lin JT, Su N, Yu HX, Gao H, Zhao JZ, Liu L. [Efficacy and safety of arbidol in treatment of naturally acquired influenza], Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2004 Jun;26(3):289-93.